Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2016-09-16

Clinical Trial Update: Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing Doxorubicin hydrochloride liposome injection with cyclophosphamide versus pirarubicin with cyclophosphamide in locally a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Doxorubicin Hydrochloride Liposome Injection (liposomal doxorubicin)
  • Pirarubicin (pirarubicin)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Breast Cancer | Phase 4 | Status: UNKNOWN